{"id":340341,"date":"2026-11-05T12:59:39","date_gmt":"2026-11-05T07:29:39","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=340341"},"modified":"2026-11-05T12:59:39","modified_gmt":"2026-11-05T07:29:39","slug":"pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/","title":{"rendered":"3 Pharma Ingredients Maker, Commodity Exchange and Transmission Towers Maker Stocks With a Strong Future Roadmap: Divi&#8217;s Laboratories, Multi Commodity Exchange of India and Karamtara Engineering"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Divi&#8217;s Laboratories, Multi Commodity Exchange of India and Karamtara Engineering: ROE of 15.3% to 46.8% and FY22 to FY26 revenue CAGR of 5.1% to 53.9%. Prices as of 4 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three API maker, commodity exchange and tower stocks to watch are Divi&#8217;s Laboratories, Multi Commodity Exchange of India and Karamtara Engineering. Their return on equity ranges from 15.3% to 46.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.1% to 53.9%. Multi Commodity Exchange of India leads on both return on equity at 46.8% and revenue growth at 53.9% a year. Prices are based on the 4 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>API maker, commodity exchange and tower stocks give investors a way to track businesses that sit close to everyday demand in India. Divi&#8217;s Laboratories, Multi Commodity Exchange of India and Karamtara Engineering cover an active pharmaceutical ingredients maker, a commodity derivatives exchange and a transmission towers maker.<\/p>\n<p>This list covers three API maker, commodity exchange and tower stocks with complete current figures: Divi&#8217;s Laboratories, Multi Commodity Exchange of India and Karamtara Engineering. Every figure comes from the latest reported financials and the 4 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/#What_Are_API_Maker_Commodity_Exchange_and_Tower_Stocks\" title=\"What Are API Maker, Commodity Exchange and Tower Stocks?\">What Are API Maker, Commodity Exchange and Tower Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/#API_Maker_Commodity_Exchange_and_Tower_Stocks_at_a_Glance\" title=\"API Maker, Commodity Exchange and Tower Stocks at a Glance\">API Maker, Commodity Exchange and Tower Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/#Why_Do_API_Maker_Commodity_Exchange_and_Tower_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do API Maker, Commodity Exchange and Tower Stocks Have a Strong Roadmap in India?\">Why Do API Maker, Commodity Exchange and Tower Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/#Why_Divis_Laboratories_Features_Among_These_API_Maker_Commodity_Exchange_and_Tower_Stocks\" title=\"Why Divi&#8217;s Laboratories Features Among These API Maker, Commodity Exchange and Tower Stocks\">Why Divi&#8217;s Laboratories Features Among These API Maker, Commodity Exchange and Tower Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/#Why_Multi_Commodity_Exchange_of_India_Features_Among_These_API_Maker_Commodity_Exchange_and_Tower_Stocks\" title=\"Why Multi Commodity Exchange of India Features Among These API Maker, Commodity Exchange and Tower Stocks\">Why Multi Commodity Exchange of India Features Among These API Maker, Commodity Exchange and Tower Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/#Why_Karamtara_Engineering_Features_Among_These_API_Maker_Commodity_Exchange_and_Tower_Stocks\" title=\"Why Karamtara Engineering Features Among These API Maker, Commodity Exchange and Tower Stocks\">Why Karamtara Engineering Features Among These API Maker, Commodity Exchange and Tower Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/#Divis_Laboratories_vs_Multi_Commodity_Exchange_of_India_vs_Karamtara_Engineering_on_Key_Financials\" title=\"Divi&#8217;s Laboratories vs Multi Commodity Exchange of India vs Karamtara Engineering on Key Financials\">Divi&#8217;s Laboratories vs Multi Commodity Exchange of India vs Karamtara Engineering on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/#Key_Risks_to_Check_Before_Investing_in_API_Maker_Commodity_Exchange_and_Tower_Stocks\" title=\"Key Risks to Check Before Investing in API Maker, Commodity Exchange and Tower Stocks\">Key Risks to Check Before Investing in API Maker, Commodity Exchange and Tower Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/#Final_Thoughts_on_API_Maker_Commodity_Exchange_and_Tower_Stocks\" title=\"Final Thoughts on API Maker, Commodity Exchange and Tower Stocks\">Final Thoughts on API Maker, Commodity Exchange and Tower Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/#What_are_API_maker_commodity_exchange_and_tower_stocks\" title=\"What are API maker, commodity exchange and tower stocks?\">What are API maker, commodity exchange and tower stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/#Which_API_maker_commodity_exchange_and_tower_stocks_are_covered_in_this_list\" title=\"Which API maker, commodity exchange and tower stocks are covered in this list?\">Which API maker, commodity exchange and tower stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/#Why_do_API_maker_commodity_exchange_and_tower_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do API maker, commodity exchange and tower stocks have a strong future roadmap in India?\">Why do API maker, commodity exchange and tower stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/#How_has_Divis_Laboratories_performed_financially\" title=\"How has Divi&#8217;s Laboratories performed financially?\">How has Divi&#8217;s Laboratories performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/#How_has_Multi_Commodity_Exchange_of_India_performed_financially\" title=\"How has Multi Commodity Exchange of India performed financially?\">How has Multi Commodity Exchange of India performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/#How_has_Karamtara_Engineering_performed_financially\" title=\"How has Karamtara Engineering performed financially?\">How has Karamtara Engineering performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/#What_risks_should_investors_check_before_buying_API_maker_commodity_exchange_and_tower_stocks\" title=\"What risks should investors check before buying API maker, commodity exchange and tower stocks?\">What risks should investors check before buying API maker, commodity exchange and tower stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker-stocks-roadmap-skylark-list\/#Is_this_list_of_API_maker_commodity_exchange_and_tower_stocks_investment_advice\" title=\"Is this list of API maker, commodity exchange and tower stocks investment advice?\">Is this list of API maker, commodity exchange and tower stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_API_Maker_Commodity_Exchange_and_Tower_Stocks\"><\/span><strong>What Are API Maker, Commodity Exchange and Tower Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>API maker, commodity exchange and tower stocks are listed companies that make active ingredients and intermediates for global drug makers, run a leading commodity derivatives exchange, and build transmission line towers and monopoles for power utilities. Their earnings depend on global drug orders, trading activity and grid projects.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"API_Maker_Commodity_Exchange_and_Tower_Stocks_at_a_Glance\"><\/span><strong>API Maker, Commodity Exchange and Tower Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi's-laboratories-ltd-share-price-today\">Divi&#8217;s Laboratories<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10,037.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">241,311<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">82.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/mcx\/multi-commodity-exchange-of-india-ltd-share-price-today\">Multi Commodity Exchange of India<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,315<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">81,189<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">52.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">41.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">46.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/karamtara\/karamtara-engineering-ltd-share-price-today\">Karamtara Engineering<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">383<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11,949<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">52.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">43.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.91<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, all three trade at a P\/E above their industry P\/E, which reflects the growth the market already expects from them. Readers comparing API maker, commodity exchange and tower stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_API_Maker_Commodity_Exchange_and_Tower_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do API Maker, Commodity Exchange and Tower Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>API maker, commodity exchange and tower stocks have a strong roadmap in India because rising global pharma outsourcing, growing hedging and trading activity and large grid investment keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Pharma ingredients.<\/strong> Global drug makers need dependable suppliers.<\/li>\n<li><strong>Commodity exchange.<\/strong> Traders and hedgers use contracts.<\/li>\n<li><strong>Transmission towers.<\/strong> Grid projects need new lines.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Divis_Laboratories_Features_Among_These_API_Maker_Commodity_Exchange_and_Tower_Stocks\"><\/span><strong>Why Divi&#8217;s Laboratories Features Among These API Maker, Commodity Exchange and Tower Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the API maker, commodity exchange and tower stocks on this list, Divi&#8217;s Laboratories is a Hyderabad-based maker of active pharmaceutical ingredients, intermediates and custom synthesis products, serving large global pharma companies from large-scale manufacturing sites.<\/p>\n<p>The company has a return on equity of 15.3%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 241,311 crore. The stock trades at a P\/E of 82.5, above the industry P\/E of 36.0.<\/p>\n<p>Revenue rose from Rs 9,074 crore in FY22 to Rs 11,067 crore in FY26, a compound annual growth rate of 5.1%. Net profit grew from Rs 1,823 crore in FY23 to Rs 2,568 crore in FY26, which works out to a compound annual growth rate of 12.1%. In the June 2026 quarter, revenue grew 24.3% year on year to Rs 3,144 crore, while net profit rose 65.5% to Rs 902 crore.<\/p>\n<p><strong>Roadmap:<\/strong> The company is a key supplier of ingredients for several widely used generics and has long-standing contract manufacturing relationships with global innovators. Capacity additions at its sites and a growing custom synthesis pipeline support future volumes.<\/p>\n<p><strong>What to watch:<\/strong> Check the order flow in custom synthesis and the commissioning of new capacity.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Multi_Commodity_Exchange_of_India_Features_Among_These_API_Maker_Commodity_Exchange_and_Tower_Stocks\"><\/span><strong>Why Multi Commodity Exchange of India Features Among These API Maker, Commodity Exchange and Tower Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the pharma, market and power shares on this list, Multi Commodity Exchange of India, known as MCX, is the country&#8217;s leading commodity derivatives exchange, offering futures and options in bullion, base metals, energy and agricultural products.<\/p>\n<p>Revenue rose from Rs 433 crore in FY22 to Rs 2,429 crore in FY26, a compound annual growth rate of 53.9%. Net profit grew from Rs 143 crore in FY22 to Rs 1,332 crore in FY26, which works out to a compound annual growth rate of 74.5%.<\/p>\n<p>The company has a return on equity of 46.8%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 81,189 crore. The stock trades at a P\/E of 52.7, above the industry P\/E of 41.8.<\/p>\n<p><strong>Roadmap:<\/strong> Volatility in gold, silver and crude oil and the growth of options trading lift volumes on the exchange. A new trading platform and a wider product range, including more contracts, support its roadmap.<\/p>\n<p><strong>What to watch:<\/strong> Follow trading volumes, since earnings track market activity and regulatory changes.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Karamtara_Engineering_Features_Among_These_API_Maker_Commodity_Exchange_and_Tower_Stocks\"><\/span><strong>Why Karamtara Engineering Features Among These API Maker, Commodity Exchange and Tower Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Karamtara Engineering makes transmission line towers, monopoles and structures for power utilities, and also supplies solar mounting structures.<\/p>\n<p>Revenue rose from Rs 1,247 crore in FY22 to Rs 4,316 crore in FY26, a compound annual growth rate of 36.4%. Net profit grew from Rs 103 crore in FY24 to Rs 229 crore in FY26, which works out to a compound annual growth rate of 49.3%.<\/p>\n<p>The company has a return on equity of 18.8%, a debt to equity ratio of 0.91 and a market capitalisation of Rs 11,949 crore. The stock trades at a P\/E of 52.2, above the industry P\/E of 43.9.<\/p>\n<p><strong>Roadmap:<\/strong> Large transmission corridors and renewable energy connections create sustained demand for towers and structures. The company is widening its capacity and its customer base, which includes state utilities and power grid developers.<\/p>\n<p><strong>What to watch:<\/strong> Keep an eye on order execution timelines and steel price movements.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Divis_Laboratories_vs_Multi_Commodity_Exchange_of_India_vs_Karamtara_Engineering_on_Key_Financials\"><\/span><strong>Divi&#8217;s Laboratories vs Multi Commodity Exchange of India vs Karamtara Engineering on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three API maker, commodity exchange and tower stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Divi&#8217;s Laboratories<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9,074<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11,067<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5.1%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,568<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Multi Commodity Exchange of India<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">433<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,429<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">53.9%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,332<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">54.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Karamtara Engineering<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,247<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,316<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.4%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">229<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5.3%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Multi Commodity Exchange of India posts the highest return on equity in this group at 46.8%. Divi&#8217;s Laboratories has the largest FY26 revenue at Rs 11,067 crore, and Multi Commodity Exchange of India shows the fastest revenue growth with a 53.9% compound annual rate. A useful habit with API maker, commodity exchange and tower stocks is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_API_Maker_Commodity_Exchange_and_Tower_Stocks\"><\/span><strong>Key Risks to Check Before Investing in API Maker, Commodity Exchange and Tower Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these API maker, commodity exchange and tower stocks, the main points are: Long-term pharma, market and power shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Regulatory approvals.<\/strong> Plant inspections and approvals can affect supplies.<\/li>\n<li><strong>Order timing.<\/strong> Project awards can shift between periods.<\/li>\n<li><strong>Valuation levels.<\/strong> Some of these companies trade at high earnings multiples, so growth must continue to justify them.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter API maker, commodity exchange and tower stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_API_Maker_Commodity_Exchange_and_Tower_Stocks\"><\/span><strong>Final Thoughts on API Maker, Commodity Exchange and Tower Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>API maker, commodity exchange and tower stocks work best when investors track growth, valuation and return on equity side by side. Divi&#8217;s Laboratories, Multi Commodity Exchange of India and Karamtara Engineering each have a clear plan to grow. Based on the 4 November 2026 close, Divi&#8217;s Laboratories trades at Rs 10,037.5, Multi Commodity Exchange of India at Rs 3,315 and Karamtara Engineering at Rs 383. Valuation matters as much as growth, so compare each company&#8217;s P\/E with its industry P\/E before adding any of these API maker, commodity exchange and tower stocks to a watchlist.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track API maker, commodity exchange and tower stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_API_maker_commodity_exchange_and_tower_stocks\"><\/span><strong>What are API maker, commodity exchange and tower stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> API maker, commodity exchange and tower stocks are listed companies that make active ingredients and intermediates for global drug makers, run a leading commodity derivatives exchange, and build transmission line towers and monopoles for power utilities. Their earnings depend on global drug orders, trading activity and grid projects. This list looks at three of them, Divi&#8217;s Laboratories, Multi Commodity Exchange of India and Karamtara Engineering, using reported FY22 to FY26 financials and the 4 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_API_maker_commodity_exchange_and_tower_stocks_are_covered_in_this_list\"><\/span><strong>Which API maker, commodity exchange and tower stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Divi&#8217;s Laboratories, Multi Commodity Exchange of India and Karamtara Engineering. Based on the 4 November 2026 close, Divi&#8217;s Laboratories traded at Rs 10,037.5, Multi Commodity Exchange of India at Rs 3,315 and Karamtara Engineering at Rs 383. Their return on equity ranges from 15.3% to 46.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.1% to 53.9%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_API_maker_commodity_exchange_and_tower_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do API maker, commodity exchange and tower stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> API maker, commodity exchange and tower stocks have a strong roadmap in India because rising global pharma outsourcing, growing hedging and trading activity and large grid investment keep widening the market for these companies. The main drivers are as follows. Pharma ingredients. Global drug makers need dependable suppliers. Commodity exchange. Traders and hedgers use contracts. Transmission towers. Grid projects need new lines. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Divis_Laboratories_performed_financially\"><\/span><strong>How has Divi&#8217;s Laboratories performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 9,074 crore in FY22 to Rs 11,067 crore in FY26, a compound annual growth rate of 5.1%. Net profit grew from Rs 1,823 crore in FY23 to Rs 2,568 crore in FY26, which works out to a compound annual growth rate of 12.1%. In the June 2026 quarter, revenue grew 24.3% year on year to Rs 3,144 crore, while net profit rose 65.5% to Rs 902 crore. The company has a return on equity of 15.3%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 241,311 crore. The stock trades at a P\/E of 82.5, above the industry P\/E of 36.0. Looking ahead, the company is a key supplier of ingredients for several widely used generics and has long-standing contract manufacturing relationships with global innovators. Capacity additions at its sites and a growing custom synthesis pipeline support future volumes.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Multi_Commodity_Exchange_of_India_performed_financially\"><\/span><strong>How has Multi Commodity Exchange of India performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 433 crore in FY22 to Rs 2,429 crore in FY26, a compound annual growth rate of 53.9%. Net profit grew from Rs 143 crore in FY22 to Rs 1,332 crore in FY26, which works out to a compound annual growth rate of 74.5%. The company has a return on equity of 46.8%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 81,189 crore. The stock trades at a P\/E of 52.7, above the industry P\/E of 41.8. Looking ahead, volatility in gold, silver and crude oil and the growth of options trading lift volumes on the exchange. A new trading platform and a wider product range, including more contracts, support its roadmap.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Karamtara_Engineering_performed_financially\"><\/span><strong>How has Karamtara Engineering performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 1,247 crore in FY22 to Rs 4,316 crore in FY26, a compound annual growth rate of 36.4%. Net profit grew from Rs 103 crore in FY24 to Rs 229 crore in FY26, which works out to a compound annual growth rate of 49.3%. The company has a return on equity of 18.8%, a debt to equity ratio of 0.91 and a market capitalisation of Rs 11,949 crore. The stock trades at a P\/E of 52.2, above the industry P\/E of 43.9. Looking ahead, large transmission corridors and renewable energy connections create sustained demand for towers and structures. The company is widening its capacity and its customer base, which includes state utilities and power grid developers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_API_maker_commodity_exchange_and_tower_stocks\"><\/span><strong>What risks should investors check before buying API maker, commodity exchange and tower stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying API maker, commodity exchange and tower stocks. Regulatory approvals. Plant inspections and approvals can affect supplies. Order timing. Project awards can shift between periods. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_API_maker_commodity_exchange_and_tower_stocks_investment_advice\"><\/span><strong>Is this list of API maker, commodity exchange and tower stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 4 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are API maker, commodity exchange and tower stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"API maker, commodity exchange and tower stocks are listed companies that make active ingredients and intermediates for global drug makers, run a leading commodity derivatives exchange, and build transmission line towers and monopoles for power utilities. Their earnings depend on global drug orders, trading activity and grid projects. This list looks at three of them, Divi's Laboratories, Multi Commodity Exchange of India and Karamtara Engineering, using reported FY22 to FY26 financials and the 4 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which API maker, commodity exchange and tower stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Divi's Laboratories, Multi Commodity Exchange of India and Karamtara Engineering. Based on the 4 November 2026 close, Divi's Laboratories traded at Rs 10,037.5, Multi Commodity Exchange of India at Rs 3,315 and Karamtara Engineering at Rs 383. Their return on equity ranges from 15.3% to 46.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.1% to 53.9%.\"}},{\"@type\":\"Question\",\"name\":\"Why do API maker, commodity exchange and tower stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"API maker, commodity exchange and tower stocks have a strong roadmap in India because rising global pharma outsourcing, growing hedging and trading activity and large grid investment keep widening the market for these companies. The main drivers are as follows. Pharma ingredients. Global drug makers need dependable suppliers. Commodity exchange. Traders and hedgers use contracts. Transmission towers. Grid projects need new lines. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Divi's Laboratories performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 9,074 crore in FY22 to Rs 11,067 crore in FY26, a compound annual growth rate of 5.1%. Net profit grew from Rs 1,823 crore in FY23 to Rs 2,568 crore in FY26, which works out to a compound annual growth rate of 12.1%. In the June 2026 quarter, revenue grew 24.3% year on year to Rs 3,144 crore, while net profit rose 65.5% to Rs 902 crore. The company has a return on equity of 15.3%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 241,311 crore. The stock trades at a P\/E of 82.5, above the industry P\/E of 36.0. Looking ahead, the company is a key supplier of ingredients for several widely used generics and has long-standing contract manufacturing relationships with global innovators. Capacity additions at its sites and a growing custom synthesis pipeline support future volumes.\"}},{\"@type\":\"Question\",\"name\":\"How has Multi Commodity Exchange of India performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 433 crore in FY22 to Rs 2,429 crore in FY26, a compound annual growth rate of 53.9%. Net profit grew from Rs 143 crore in FY22 to Rs 1,332 crore in FY26, which works out to a compound annual growth rate of 74.5%. The company has a return on equity of 46.8%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 81,189 crore. The stock trades at a P\/E of 52.7, above the industry P\/E of 41.8. Looking ahead, volatility in gold, silver and crude oil and the growth of options trading lift volumes on the exchange. A new trading platform and a wider product range, including more contracts, support its roadmap.\"}},{\"@type\":\"Question\",\"name\":\"How has Karamtara Engineering performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 1,247 crore in FY22 to Rs 4,316 crore in FY26, a compound annual growth rate of 36.4%. Net profit grew from Rs 103 crore in FY24 to Rs 229 crore in FY26, which works out to a compound annual growth rate of 49.3%. The company has a return on equity of 18.8%, a debt to equity ratio of 0.91 and a market capitalisation of Rs 11,949 crore. The stock trades at a P\/E of 52.2, above the industry P\/E of 43.9. Looking ahead, large transmission corridors and renewable energy connections create sustained demand for towers and structures. The company is widening its capacity and its customer base, which includes state utilities and power grid developers.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying API maker, commodity exchange and tower stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying API maker, commodity exchange and tower stocks. Regulatory approvals. Plant inspections and approvals can affect supplies. Order timing. Project awards can shift between periods. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of API maker, commodity exchange and tower stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 4 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>API Maker, Commodity Exchange and Tower Stocks with a strong future roadmap: Divi&#8217;s Laboratories, Multi Commodity Exchange of India and Karamtara Engineering. Compare price, valuation, return on equity and revenue growth as of 4 November 2026.<\/p>\n","protected":false},"author":28,"featured_media":340340,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[19524,3803,20441,457,18535,20443,9264,20442,14760],"class_list":["post-340341","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-api-maker","tag-best-stocks","tag-commodity-exchange-and-tower-stocks","tag-divis-laboratories","tag-drug-ingredient","tag-futures-trading-and-pylon-stocks","tag-karamtara-engineering","tag-market-and-power-shares","tag-multi-commodity-exchange-of-india"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["340340"],"rank_math_title":["API, Commodity Exchange and Tower Stocks"],"rank_math_description":["Compare 3 API maker, commodity exchange and tower stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 4 Nov 2026."],"rank_math_focus_keyword":["API maker, commodity exchange and tower stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-pharma-ingredients-maker-commodity-exchange-and-transmission-towers-maker.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/340341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=340341"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/340341\/revisions"}],"predecessor-version":[{"id":340342,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/340341\/revisions\/340342"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/340340"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=340341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=340341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=340341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}